Makro-Albumon (Human Serum Albumin)

Human Serum Albumin acts as a high‑molecular‑weight colloid that raises plasma oncotic pressure. By retaining water within the vascular space, it expands circulating blood volume, improves tissue perfusion, and serves as a carrier for fatty acids, hormones, and certain drugs.

The dose of Makro-Albumon is individualized. The prescribing clinician determines the amount and infusion rate based on the patient’s clinical condition, fluid status, and target serum albumin level. No standard dosing regimen is provided in public literature.

Human Serum Albumin is classified as pregnancy category unknown. Limited data exist, so the product should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Breastfeeding considerations follow the same risk‑benefit assessment.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Makro-Albumon (human albumin) is a natural protein‑based colloid, whereas synthetic options such as hydroxyethyl starch or gelatin are polymeric. Albumin generally has a lower risk of coagulopathy and renal injury, but it is more expensive and requires refrigerated storage.

Makro-Albumon must be stored at 2‑8 °C, protected from light, and kept in its original container. It should not be frozen or shaken vigorously, as this can cause protein denaturation and reduce product efficacy.

The product is given by intravenous infusion. Administration rate is determined by the prescriber, often starting with a slow initial infusion to assess tolerance, followed by adjustment based on the patient’s hemodynamic response and target plasma albumin level.

Serious risks include anaphylactic reactions, volume overload leading to pulmonary edema, and rare events such as hemolysis or thrombosis. Prompt recognition and immediate discontinuation of the infusion are essential if these events occur.

Makro-Albumon is contraindicated in patients with known hypersensitivity to human serum albumin, severe congestive heart failure, uncontrolled pulmonary edema, or those in whom volume overload would pose a significant risk.